Lead study author Jane Figueiredo, PhD, and her team looked at data from more than 2,500 people enrolled in the American Cancer Society Cancer Prevention Study-II nutrition cohort, according to a March 29 news release. Everyone shared their aspirin and non-aspirin NSAID use and were eventually diagnosed with CRC.
The study, published in the Journal of the National Cancer Institute, found participants who started regular aspirin after a CRC diagnosis also had better outcomes than those who didn’t use aspirin, but there wasn’t enough benefit to be significant. Clinical trials are ongoing to explore aspirin use and CRC mortality.
“These findings may provide an inexpensive lifestyle option to people seeking to prevent colorectal cancer, or to improve their prognoses if they are diagnosed,” Dr. Figueiredo said.
More articles on surgery centers:
10 ASC administrators to know
Why an independent ASC in California steers clear of private equity
Did the pandemic change ASC-hospital relationships?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.